• CAS No.：
  2036272-55-4
• Synonyms：
  ((4-Hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate)
  Decanoic acid, 2-hexyl-, 1,1'-[[(4-hydroxybutyl)imino]di-6,1-hexanediyl] ester
  6-[6-(2-Hexyldecanoyloxy)hexyl-(4-hydroxybutyl)amino]hexyl 2-hexyldecanoate
  
• MF：
  C₄₈H₉₅NO₅
• MW：
  766.27
• Recommended Storage Condition：
  
• Uses：
  

ALC-0315 functions as a cationic lipid, and its significance arises as a colorless, oily substance included in the SARS-CoV-2 vaccine, BNT162b2, developed by BioNTech and Pfizer. Within this vaccine, ALC-0315 is one of four crucial components constituting lipid nanoparticles (LNPs). These LNPs serve the crucial role of encapsulating and safeguarding the otherwise delicate mRNA, which acts as the active ingredient in the vaccine. Importantly, these nanoparticles play a pivotal role in enhancing the uptake of therapeutically effective nucleic acids, such as oligonucleotides or mRNA, both in laboratory settings (in vitro) and within living organisms (in vivo).